Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tove Agner

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Contact Dermatitis|December 22, 2017
Allergic contact dermatitis caused by nail acrylates in Europe. An EECDRG studyMargarida Gonçalo, André Pinho, Tove Agner, et al.
Contact Dermatitis|June 10, 2008
Decreasing trends in methyldibromo glutaronitrile contact allergy--following regulatory interventionJeanne D Johansen, Niels Veien, Grete Laurberg, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
BMC Microbiology|September 29, 2023
A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controlsChristopher J Barnes, Maria Asplund, Maja-Lisa Clausen, et al.
Contact Dermatitis|October 6, 2012
Patch testing with 2.0% (0.60 mg/cm 2) formaldehyde instead of 1.0% (0.30 mg/cm 2) detects significantly more contact allergyAnn Pontén, Kristiina Aalto-Korte, Tove Agner, et al.
Lancet (London, England)|April 12, 2025
Reflections on chronic hand eczema - Authors' replyRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Contact Dermatitis|June 21, 2013
Contact allergy to common ingredients in hair dyesHeidi Søsted, Thomas Rustemeyer, Margarida Gonçalo, et al.
Contact Dermatitis|December 30, 2016
The epidemic of methylisothiazolinone: a European prospective studyJakob F Schwensen, Wolfgang Uter, Magnus Bruze, et al.
Acta Dermato-Venereologica|June 7, 2022
Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment RegistryHenrik H.P. Larsen, Ida Vittrup, Iben F. Ruge, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Contact Dermatitis|December 22, 2017
Allergic contact dermatitis caused by nail acrylates in Europe. An EECDRG studyMargarida Gonçalo, André Pinho, Tove Agner, et al.
Contact Dermatitis|June 10, 2008
Decreasing trends in methyldibromo glutaronitrile contact allergy--following regulatory interventionJeanne D Johansen, Niels Veien, Grete Laurberg, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
BMC Microbiology|September 29, 2023
A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controlsChristopher J Barnes, Maria Asplund, Maja-Lisa Clausen, et al.
Contact Dermatitis|October 6, 2012
Patch testing with 2.0% (0.60 mg/cm 2) formaldehyde instead of 1.0% (0.30 mg/cm 2) detects significantly more contact allergyAnn Pontén, Kristiina Aalto-Korte, Tove Agner, et al.
Lancet (London, England)|April 12, 2025
Reflections on chronic hand eczema - Authors' replyRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Contact Dermatitis|June 21, 2013
Contact allergy to common ingredients in hair dyesHeidi Søsted, Thomas Rustemeyer, Margarida Gonçalo, et al.
Contact Dermatitis|December 30, 2016
The epidemic of methylisothiazolinone: a European prospective studyJakob F Schwensen, Wolfgang Uter, Magnus Bruze, et al.
Acta Dermato-Venereologica|June 7, 2022
Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment RegistryHenrik H.P. Larsen, Ida Vittrup, Iben F. Ruge, et al.
Pageof 18